Yunkai Zhang

3.2k citations

95 papers · 2.2k indexed · 1 hit paper · h-index 31

Molecular Biology top 10%
Oncology top 5%
Cancer Research top 10%
Pulmonary and Respiratory Medicine top 10%
Immunology

Co-authors: Zhe‐Sheng Chen Yi‐Jun Wang Pranav Gupta Guan-Nan Zhang Xingguang Liu Dong‐Hua Yang Tanaji T. Talele Jianfeng Ma
Topics: Drug Transport and Resistance Mechanisms (28 papers)Network Security and Intrusion Detection (12 papers)Cancer therapeutics and mechanisms (11 papers)
Cited by: Oncology Molecular Biology Cancer Research
Journals: Proceedings of the National Academy of Sciences Circulation Nature Communications
Partner nations: China United States South Korea

In The Last Decade

Yunkai Zhang

91 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rheumatoid arthritis: pathogenesis and therapeutic advances

2024 51 citations Yunkai Zhang et al. profile →

Peers

Countries citing papers authored by Yunkai Zhang

Since Specialization

Citations

This map shows the geographic impact of Yunkai Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunkai Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunkai Zhang more than expected).

Fields of papers citing papers by Yunkai Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunkai Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunkai Zhang. The network helps show where Yunkai Zhang may publish in the future.

Co-authorship network of co-authors of Yunkai Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yunkai Zhang. A scholar is included among the top collaborators of Yunkai Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunkai Zhang. Yunkai Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 2025 ·Drug Resistance Updates ·Zhenfang Du,(unknown),(unknown),Yue Liu,(unknown),(unknown),Yang Zou,(unknown),(unknown),Chen Li,Lei Luo,Yunkai Zhang,Hong Fan,(unknown),Bo Wang	5
2	A multivariate time series anomaly detection method with Multi-Grain Dynamic Receptive Field 2024 ·Knowledge-Based Systems ·Lingli Chen,Xin Gao,Jing Liu,Yunkai Zhang,(unknown),(unknown),(unknown),(unknown)	3
3	Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism 2024 ·Circulation ·Sheng Zhang,Yunkai Zhang,(unknown),(unknown),Zhenzhen Zhan	35
4	Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis 2023 ·Signal Transduction and Targeted Therapy ·Ying Dong,Hao Hu,Xuan Zhang,Yunkai Zhang,Xin Sun,Hanlin Wang,Weijuan Kan,Minjia Tan,Hong Shi,Yi Zang,Jia Li	34
5	Antibiotics Development and the Potentials of Marine-Derived Compounds to Stem the Tide of Multidrug-Resistant Pathogenic Bacteria, Fungi, and Protozoa 2020 ·Marine Drugs ·Justus Amuche Nweze,(unknown),Gang Huang,Yanming Li,Liyan Yang,Yunkai Zhang,Shushi Huang,Lixia Pan,Dengfeng Yang	41
6	Lipid–Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo 2020 ·Cancers ·Guan-Nan Zhang,Pranav Gupta,Ming Wang,(unknown),Charles R. Ashby,Yunkai Zhang,Leli Zeng,Qiaobing Xu,Yingfang Fan,Zhe‐Sheng Chen	11
7	ABCG2 Overexpression Contributes to Pevonedistat Resistance 2020 ·Cancers ·Rishil J. Kathawala,Claudia M. Espitia,(unknown),(unknown),Pranav Gupta,Yunkai Zhang,Zhe‐Sheng Chen,Jennifer S. Carew,Steffan T. Nawrocki	13
8	Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor 2020 ·Biochemical Pharmacology ·Chao‐Yun Cai,Wei Zhang,Jing‐Quan Wang,Zi‐Ning Lei,Yunkai Zhang,Yi‐Jun Wang,Pranav Gupta,Cai‐Ping Tan,Bo Wang,Zhe‐Sheng Chen	28
9	On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation 2019 ·Clinical Cancer Research ·Benjamin P. Brown,Yunkai Zhang,David Westover,Yingjun Yan,Huan Qiao,Vincent Huang,Zhenfang Du,Jarrod A. Smith,Jeffrey S. Ross,Vincent A. Miller,Siraj M. Ali,Lyudmila Bazhenova,Alexa B. Schrock,Jens Meiler,Christine M. Lovly	76
10	An organoruthenium complex overcomes ABCG2-mediated multidrug resistance via multiple mechanisms 2019 ·Chemical Communications ·Leli Zeng,Jia Li,Chen Zhang,Yunkai Zhang,(unknown),Juanjuan Huang,Charles R. Ashby,Zhe‐Sheng Chen,Hui Chao	12
11	Benzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistance 2019 ·European Journal of Medicinal Chemistry ·Chao‐Yun Cai,(unknown),Zi‐Ning Lei,Cai‐Ping Tan,Baoli Chen,(unknown),Jing‐Quan Wang,Yunkai Zhang,Yi‐Jun Wang,Pranav Gupta,Bo Wang,Zhe‐Sheng Chen	33
12	Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo 2018 ·Cancer Letters ·Guan-Nan Zhang,Yunkai Zhang,Yi‐Jun Wang,Pranav Gupta,Charles R. Ashby,Saeed Alqahtani,(unknown),Susan E. Bates,Amal Kaddoumi,John N.D. Wurpel,Yixiong Lei,Zhe‐Sheng Chen	48
13	Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer 2018 ·Cancer Letters ·Yunkai Zhang,Yi‐Jun Wang,Zi‐Ning Lei,Guan-Nan Zhang,Xiaoyu Zhang,De‐Shen Wang,(unknown),Suneet Shukla,Suresh V. Ambudkar,Amal Kaddoumi,Zhi Shi,Zhe‐Sheng Chen	39
14	A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway 2017 ·Journal of Medicinal Chemistry ·Shengtao Xu,Hong Yao,Shanshan Luo,Yunkai Zhang,Dong‐Hua Yang,Dahong Li,Guangyu Wang,Mei Hu,(unknown),Jinhui Wu,Hequan Yao,Weijia Xie,Zhe‐Sheng Chen,Jinyi Xu	97
15	Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells 2016 ·Molecules ·Xiaoyu Zhang,Yunkai Zhang,Yi‐Jun Wang,Pranav Gupta,Leli Zeng,(unknown),Xiuqi Wang,Dong‐Hua Yang,Zhe‐Sheng Chen	39
16	Stability Analysis of a Worm Propagation Model with Quarantine and Vaccination 2016 ·International journal of network security ·(unknown),(unknown),Changguang Wang,Dongmei Zhao,Yunkai Zhang	2
17	Esters of the Marine-Derived Triterpene Sipholenol A Reverse P-GP-Mediated Drug Resistance 2015 ·Marine Drugs ·Yongchao Zhang,Yunkai Zhang,Yi‐Jun Wang,(unknown),Sandeep Jain,(unknown),(unknown),Diaa T. A. Youssef,Khalid A. El Sayed,Zhe‐Sheng Chen	17
18	Lamellarin O, a Pyrrole Alkaloid from an Australian Marine Sponge, Ianthella sp., Reverses BCRP Mediated Drug Resistance in Cancer Cells 2014 ·Marine Drugs ·Xiao‐Cong Huang,Xue Xiao,Yunkai Zhang,Tanaji T. Talele,Angela A. Salim,Zhe‐Sheng Chen,Robert J. Capon	66
19	Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1 2014 ·Biochemical Pharmacology ·Yi‐Jun Wang,Rishil J. Kathawala,Yunkai Zhang,Atish Patel,Priyank Kumar,Suneet Shukla,King Leung Fung,Suresh V. Ambudkar,Tanaji T. Talele,Zhe‐Sheng Chen	48
20	Modelling and Analyzing Passive Worms over Unstructured Peer-to-Peer Networks 2010 ·International journal of network security ·(unknown),Yunkai Zhang,Jianfeng Ma	4

About Yunkai Zhang

Yunkai Zhang is a scholar working on Oncology, Biotechnology and Molecular Biology, having authored 95 papers that have together received 2.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (28 papers), Network Security and Intrusion Detection (12 papers) and Cancer therapeutics and mechanisms (11 papers). The work is most often cited by research in Oncology (866 citations), Molecular Biology (1.1k citations) and Cancer Research (232 citations). Yunkai Zhang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Zhe‐Sheng Chen, Yi‐Jun Wang, Pranav Gupta, Guan-Nan Zhang, Xingguang Liu, Dong‐Hua Yang, Tanaji T. Talele, Jianfeng Ma, Rishil J. Kathawala and Charles R. Ashby. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact